Drugmaker Acorda Plunges After Deaths in Parkinson's Trial

(Bloomberg) -- Acorda Therapeutics Inc. plunged by a record 40 percent after patients died in final-stage studies of a treatment for Parkinson’s disease, in a fresh blow to a drugmaker that had sta...

Bloomberg Quint

Add BloombergQuint App to Home screen.